Recombinant Streptavidin Protein (MALS verified)

제품 번호/규격
가격
Availability
수량
STN-N5116-5mg (1mg X 5)
$235.00
In Stock - Delivery in 1-2 business days
STN-N5116
제품 금액 :
$ 0
신제품 제안 Request Quote
Contact Us
Contact Us
제품 금액:
$ 0
  • 제품 세부정보
  • 데이터 표시
  • Reviews & Citations
  • Important Statement
  • Resources
Synonyms

Streptavidin, SA

Source

Recombinant Streptavidin (STN-N5116) is expressed from E. coli cells.

Molecular Characterization

This protein carries no "tag".

The protein has a calculated MW of 13.8 kDa. The protein migrates as 12 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

The protein is designed as a tetramer.

Application

ELISA assay

Purity

>95% as determined by SDS-PAGE.

>95% as determined by SEC-MALS.

Formulation

Lyophilized from 0.22 μm filtered solution in NaCl, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Shipping and Storage

This product is shipped at ambient temperature.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 2 years in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.

배경 소개

Streptavidin is a tetrameric protein purified from the bacterium Streptomyces avidinii, and exhibits high binding affinity for biotin. Able to bind one molecule of biotin with each subunit. Streptavidin (PI=6.0-7.5) has lower level of non-specific binding to various biological components at physiological pH than avidin (PI=7.4), resulting from its isoelectric point (PI).Streptavidin is useful in affinity chromatography, ELISA, immunohistochemistry and Western Blotting.

ACRO Scientific Leadership Award

Supporting the scientists driving cell & gene therapy forward

Apply Now